KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $6.02 $13.63 Friday, 26th Apr 2024 VERV stock ended at $6.16. This is 0.96% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.47% from a day low at $6.02 to a day high of $6.41.
90 days $6.02 $19.34
52 weeks $6.02 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Aug 16, 2023 $15.73 $15.89 $15.01 $15.02 596 777
Aug 15, 2023 $16.82 $16.89 $15.57 $15.80 803 069
Aug 14, 2023 $17.71 $17.71 $16.59 $17.07 611 991
Aug 11, 2023 $18.09 $18.18 $17.27 $17.98 420 659
Aug 10, 2023 $18.15 $18.59 $17.30 $18.00 465 026
Aug 09, 2023 $17.34 $17.65 $17.07 $17.53 552 796
Aug 08, 2023 $16.15 $17.58 $16.09 $17.54 901 872
Aug 07, 2023 $18.91 $18.91 $16.32 $16.34 1 454 042
Aug 04, 2023 $19.12 $19.31 $18.73 $18.95 452 730
Aug 03, 2023 $18.91 $19.31 $18.49 $18.92 347 204
Aug 02, 2023 $19.04 $19.21 $18.38 $19.12 479 433
Aug 01, 2023 $20.23 $20.31 $19.00 $19.42 420 608
Jul 31, 2023 $19.90 $20.58 $19.84 $20.49 307 757
Jul 28, 2023 $19.86 $20.51 $19.72 $19.90 340 451
Jul 27, 2023 $20.72 $20.72 $19.20 $19.46 538 748
Jul 26, 2023 $20.61 $20.98 $20.25 $20.42 371 289
Jul 25, 2023 $20.70 $21.04 $20.30 $20.74 373 881
Jul 24, 2023 $20.88 $20.88 $20.38 $20.61 452 331
Jul 21, 2023 $20.00 $20.82 $19.80 $20.82 448 679
Jul 20, 2023 $20.23 $20.29 $19.56 $19.83 401 871
Jul 19, 2023 $20.28 $21.01 $20.28 $20.35 575 425
Jul 18, 2023 $19.80 $20.33 $19.69 $20.16 574 010
Jul 17, 2023 $20.01 $20.50 $19.73 $19.78 710 760
Jul 14, 2023 $20.38 $20.64 $19.26 $19.94 695 464
Jul 13, 2023 $20.57 $20.57 $19.90 $20.36 610 440
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT